| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.35B | 10.32B | 8.53B | 7.64B | 6.37B | 5.59B |
| Gross Profit | 8.57B | 8.58B | 7.03B | 6.18B | 5.21B | 4.68B |
| EBITDA | 3.84B | 3.83B | 1.90B | 1.65B | 1.50B | 2.67B |
| Net Income | 1.69B | 1.55B | 483.46M | -6.05B | 395.33M | 10.05B |
Balance Sheet | ||||||
| Total Assets | 37.47B | 38.28B | 35.19B | 31.89B | 36.54B | 35.04B |
| Cash, Cash Equivalents and Short-Term Investments | 25.15B | 26.58B | 23.86B | 21.33B | 19.09B | 17.96B |
| Total Debt | 32.53M | 3.02B | 2.84B | 2.80B | 2.45B | 2.42B |
| Total Liabilities | 6.28B | 9.87B | 8.62B | 7.73B | 7.74B | 6.82B |
| Stockholders Equity | 25.12B | 22.46B | 21.29B | 19.50B | 24.78B | 24.66B |
Cash Flow | ||||||
| Free Cash Flow | 3.41B | 4.16B | 3.01B | 2.06B | 1.92B | 2.46B |
| Operating Cash Flow | 3.88B | 4.59B | 3.49B | 2.57B | 2.22B | 2.99B |
| Investing Cash Flow | 181.50M | -8.52B | -6.48B | 4.42B | -1.61B | -7.57B |
| Financing Cash Flow | -1.89B | -1.08B | 655.86M | -619.04M | -479.61M | 1.88B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$4.15B | 7.47 | 17.91% | 3.82% | 4.02% | -23.98% | |
73 Outperform | HK$548.36B | 18.22 | 24.72% | 2.22% | 5.45% | 32.55% | |
69 Neutral | HK$31.23B | 18.73 | 44.75% | 1.18% | 51.87% | 4031.49% | |
64 Neutral | HK$78.70B | 62.43 | 8.04% | ― | 16.59% | ― | |
62 Neutral | HK$33.23B | 9.26 | 8.02% | 0.48% | -0.11% | 12.80% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
48 Neutral | HK$4.88B | 33.82 | 2.70% | 8.76% | -23.86% | -113.19% |